Understanding Patient Experiences in Testicular Cancer Clinical Trials
This observational study aims to understand the experiences of people with testicular cancer who are invited to participate in clinical trials. It will look at why some patients decide to join a trial and why others might not, or why some might leave a trial early. Researchers hope to enroll about 500 men aged 18 or older who have been diagnosed with testicular cancer and have not yet received treatment. The study will measure how many patients choose to enroll in a trial within 3 months and how many stay in a trial until it's finished, measured at 12 months. There are no specific interventions (treatments) being tested in this study; instead, it focuses on the patient's journey through clinical research.
- Study design
- This is an observational study aiming to enroll about 500 participants. It is not testing a specific drug or treatment.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure participation at 3 months and completion rates at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Unveiling Patient Experiences in Testicular Cancer Clinical Trials
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of testicular cancer patients who decide to enroll in a clinical trial3 months
- Rate of testicular cancer patients who remain in a clinical trial to trial completion12 months